For the Inventor, By the Inventor

Enter assignee name

Stamford, CT, United States of America

Purdue Pharma L.p.

USPTO Granted Patents = 545

CIPO Patents = 7

EPO Patents = 84

Trademarks = 19

Forward Citations = 9,651

Loading Chart...

Loading Chart...

191 inventors (with patents filed for the assignee):

Benjamin Oshlack (118 out of 157 patents)

Laykea Tafesse (84 out of 91 patents)

Curtis Wright (74 out of 86 patents)

4. Donald Kyle (66 out of 316 patents)

5. Haiyong Hugh Huang (62 out of 63 patents)

6. Christopher D Breder (46 out of 56 patents)

7. Richard O Mannion (42 out of 43 patents)

8. Edward P O'Donnell (41 out of 42 patents)

9. Jiangchao Yao (41 out of 50 patents)

10. William H McKenna (40 out of 41 patents)

11. Hua-Pin Huang (39 out of 48 patents)

12. John K Masselink (36 out of 37 patents)

13. Alfred P Tonelli (34 out of 35 patents)

14. Qun Sun (28 out of 92 patents)

15. Richard S Sackler (27 out of 48 patents)

Core Competencies:

Tamper Resistant Dosage Forms

Tinostamustine

T-Cell Malignant Disease

Compounds for Treating TNBC

Sleep Disorder Treatment

Opioid Antagonist Delivery

Pharmaceutical Formulations

Indole Derivatives

Humanized Antibodies

Controlled Release Dosage Forms

Azaspiro Derivatives

Oxycodone Hydrochloride Preparation

545 patents: Sort by Forward Citations

1. 12396955 - Tamper resistant dosage forms (2025-08-26),

2. 12377076 - Compounds for treating lymphoma or a T-cell malignant disease (2025-08-05),

3. 12371427 - Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound (2025-07-29),

4. 12370191 - Treatment and prevention of sleep disorders (2025-07-29),

5. 12370178 - Tinostamustine for use in the treatment of t-cell prolymphocytic leukaemia (2025-07-29),

6. 12303492 - Compounds for treating TNBC (2025-05-20),

7. 12297199 - Morphinan derivatives and use thereof (2025-05-13),

8. 12280152 - Tamper resistant dosage forms (2025-04-21),

9. 12257237 - Tinostamustine for use in treating sarcoma (2025-03-25),

10. 12246094 - Tamper resistant dosage forms (2025-03-11),

11. 12201629 - Method of treatment and dosage forms thereof (2025-01-21),

12. 12171762 - Sleep disorder treatment and prevention (2024-12-24),

13. 12161754 - Abuse deterrent morphine sulfate dosage forms (2024-12-10),

14. 12060361 - Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone (2024-08-13),

15. 12053464 - Pharmaceutical dosage forms (2024-08-06),

Purdue Pharma L.P. is a pharmaceutical company dedicated to improving patients' lives through the development and commercialization of innovative medicines. With a focus on pain management and related therapeutic areas, they aim to address unmet medical needs. Headquartered in Stamford, Connecticut, Purdue Pharma operates worldwide, collaborating with healthcare professionals and institutions to provide effective treatment options and enhance patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

545 Patents

#5 in Stamford, CT

#22 in Connecticut

#863 in US

#1,734 in the World

Stamford, CT, United States of America

Purdue Pharma L.p.

Forward Citations = 9,651

191 inventors:

Benjamin Oshlack (118 out of 157 patents)

Laykea Tafesse (84 out of 91 patents)

Curtis Wright (74 out of 86 patents)

4. Donald Kyle (66 out of 316 patents)

5. Haiyong Hugh Huang (62 out of 63 patents)

Please report any incorrect information to support@idiyas.com

Loading…